Between February 2, 2026, and February 6, 2026, Essity Aktiebolag (publ) repurchased a total of 69,537 own Class B shares (ISIN: SE0009922164) under the framework of the buyback program as resolved by the Board of Directors.

The share purchase is part of the SEK 3bn buyback program announced by Essity on April 23, 2025. The buyback program will extend from April 24, 2025, until the 2026 Annual General Meeting and be implemented in accordance with the EU Market Abuse Regulation (MAR) and the European Commission's Delegated Regulation 2016/1052 (Safe Harbour Regulation).

The share repurchase is financed using cash flow from current operations after the ordinary dividend with the ambition to continue with share buybacks over time as a recurring part of Essity's capital allocation.

Class B shares in Essity were repurchased as follows:

DateAggregated daily volume (no. of shares):Weighted average price per day (SEK):Total daily transaction value (SEK):
February 2, 2026 13,745 263.7306 3,624,977
February 3, 2026 13,741 262.3751 3,605,296
February 4, 2026 13,332 270.2339 3,602,758
February 5, 2026 14,094 273.9927 3,861,653
February 6, 2026 14,625 278.0045 4,065,816
Total accumulated during week 6 202669,537269.791618,760,501
Total accumulated during the buyback program10,326,818258.29462,667,361,334

All purchases were conducted on Nasdaq Stockholm by BofA Securities Europe SA on behalf of Essity. Following the above purchases, Essity's holding of treasury shares amounted on February 6, 2026, to 11,109,318 Class B shares. The total number of shares in Essity amounted on the date of this press release to 693,054,489, of which 57,200,658 Class A shares and 635,853,831 Class B shares.

For additional information, please contact:
Sandra Åberg, Vice President Investor Relations, +46 70 564 96 89, sandra.aberg@essity.com

Essity is a global, leading hygiene and health company. Every day, our products, solutions and services are used by a billion people around the world. Our purpose is to break barriers to well-being for the benefit of consumers, patients, caregivers, customers and society. Sales are conducted in approximately 150 countries under the leading global brands TENA and Tork, and other strong brands such as Actimove, Cutimed, JOBST, Knix, Leukoplast, Libero, Libresse, Lotus, Modibodi, Nosotras, Saba, Tempo, TOM Organic and Zewa. In 2025, Essity had net sales of approximately SEK 138bn (EUR 13bn) and employed 36,000 people. The company's headquarters is located in Stockholm, Sweden and Essity is listed on Nasdaq Stockholm. More information at essity.com.

https://news.cision.com/essity/r/buyback-of-class-b-shares-in-essity-during-week-6--2026,c4304572

https://mb.cision.com/Main/15798/4304572/3923605.pdf

(c) 2026 Cision. All rights reserved., source Press Releases - English